Discloses the status including unpurchased shares. Total purchased shares: 0 shares, total amount: 0 yen, acquisition period: July 1\u201331, 2026 (trade date basis), acquisition method: market purchase on the Tokyo Stock Exchange. For reference, the decision announced on February 6, 2026 set a cap of 400,000 shares and 300,000,000 yen, and as of July 31, 2026 progress was 306,900 shares and 292,321,100 yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9780","jir_company_name":"Harima Biostem Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-08-03","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/9780-20260803-01.pdf","jir_short_summary":"Discloses the status including unpurchased shares. Total purchased shares: 0 shares, total amount: 0 yen, acquisition period: July 1\u201331, 2026 (trade date basis), acquisition method: market purchase on the Tokyo Stock Exchange. For reference, the decision announced on February 6, 2026 set a cap of 400,000 shares and 300,000,000 yen, and as of July 31, 2026 progress was 306,900 shares and 292,321,100 yen.","jir_summary":"### Acquisition status overview\nThe disclosed status of the share buyback announced today shows the share type as common stock, total shares acquired as 0, total acquisition amount as 0 yen, acquisition period from July 1 to July 31, 2026 (trade-date basis), and acquisition method as a market purchase on the Tokyo Stock Exchange, with no actual acquisitions to date. As reference, the February 6, 2026 disclosure stated a cap of 400,000 shares and 300 million yen, with the period from February 6, 2026 to February 5, 2027; as of July 31, 2026, progress was 306,900 shares and approximately 292,320,100 yen.\n\n### Impact on investors and future outlook\nThis disclosure aims to increase transparency of the share buyback progress. At present, no acquisitions have been made, so dilution-prevention effects are not yet realized, but the upper limit and period remain clearly set, and future buybacks are expected. The market-purchase method is subject to market conditions, and progress could be material for shareholder returns if acquisitions proceed.","jir_financial_highlights":"Total number of shares acquired: 0 shares (Unknown)\nTotal acquisition amount: 0 yen (Unknown)","jir_category":"","jir_hashtags":"#HarimaBiostem, #IR, #JapanStocks","jir_key_figures":"Total number of shares acquired: 0 shares\nTotal acquisition amount: 0 yen\nProgress as of July 31, 2026: 306,900 shares \/ 292,321,100 yen","jir_meta_title":"Harima Biostem Share Buyback Status Disclosure \uff5c As of July 31, 2026","jir_meta_description":"Harima Biostem discloses its share buyback status. The disclosure notes 0 shares and 0 yen. Includes progress from the February 2026 disclosure. Explains the current status and future outlook for investors.","jir_og_title":"Harima Biostem Share Buyback Status Disclosure \uff5c As of July 31, 2026","jir_og_description":"Harima Biostem reveals its share buyback status. Current acquisition is 0 shares, but the cap and period have been set. Monitor future progress.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":0,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-93603","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n